Questo prodotto usufruisce delle SPEDIZIONI GRATIS
selezionando l'opzione Corriere Veloce in fase di ordine.
Pagabile anche con Carta della cultura giovani e del merito, 18App Bonus Cultura e Carta del Docente
Tasman’s Psychiatry, 5th Edition, builds on the initial vision in prior editions of approaching psychiatric evaluation and care from an integrative bio-psycho-social-cultural perspective. It is designed to be an essential and accessible reference for readers at any level of experience. This editorial approach encompasses the importance of the first encounter between patient and clinician, followed by the complex task of beginning to develop a therapeutic relationship and to develop and implement a treatment plan in collaboration with the patient. The importance of increasing attention to the role of culture and social determinants of mental health is reflected both in specific chapters and in components of many chapters throughout the book, especially in those pertaining to clinical evaluation, the therapeutic alliance, and treatment. The global scope of this edition is reflected throughout the book, including the section on psychiatric disorders where evaluation using both ICD 11 and DSM 5-TR is discussed. Most chapters are authored by experts from at least two different countries or continents, adding a critically important dimension which often is missing in major psychiatric textbooks.
Tasman’s Psychiatry, 5th Edition, is an essential reference for all medical professionals and students who need a trusted reference or learning tool for psychiatry, psychology, clinical research, social work, counseling, therapy, and all others.
The Psychiatric Interview: Adapting to Diverse Settings.- Cultural and Social Context of Clinical Assessment.- Listening to the Patient.- The Physician–Patient Relationship.- The Psychiatric Interview: General Structures and Techniques.- Professional Ethics and Boundaries.- Legal Issues in Psychiatric Practice.- Psychiatric Perspective in Human Development.- Infant Development: The First 3 Years of Life.- Preschool Development.- School-Age Development.- Adolescent Development.- Adult and Midlife Development.- Late Life Development.- Development of Personality Throughout the Life Cycle.- Neurobiological Foundations of Psychiatry: Overview.- Evolutionary Psychiatry.- Genetic Epidemiology and Molecular Genetics.- Multiomics Approaches in Psychiatric Disorders.- Gut Microbiome and Psychiatric Disorders.- Gene-Environment Interactions.- Cognitive Neuroscience.- Neurobiology of Schizophrenia.- Neurobiology of Mood Disorders.- Neurobiology of Anxiety Disorders.- Neurobiology of Addiction.-Neurobiology of Autism Spectrum Disorder.- Neurobiology of Attention Deficit Hyperactivity Disorder.- Neurobiology of Dementia and Other Neurodegenerative Disorders.- Neurobiology of Neuroimmune Encephalitic Disorders.- Neurobiological Foundations of Psychotherapies.- Psychiatric Epidemiology.- Sociocultural Anthropology Models of Mental Function and Behavior.- Social Psychology Models of Mental Function and Behavior.- Psychoanalytic/Psychodynamic Models of Mental Function and Behavior.- Cognitive and Behavioral Models of Mental Function and Behavior.- Positive Psychology Model of Mental Function and Behavior.- Multimodal Clinical Evaluation and Treatment Planning.- Consciousness, Memory, and Intelligence.- Alterations of Speech, Thought, Perception, and Self-Experience.- Emotions.- Behavior and Adaptive Functioning.- Physical Signs and Symptoms.- Neuropsychological and Neurophysiological Assessment.- Brain Imaging in Psychiatry.- Integrative Neurobiological Approaches to Assessment.-Assessment Tools in Psychiatry.- Special Considerations in the Psychiatric Evaluation Across the Lifespan (Special Emphasis on Children, Adolescents, and Elderly).- Culture-Related Issues in Assessment.- Special Issues in Assessment.- The Psychiatric Formulation.- Psychiatric Classification.- Neurodevelopmental Disorders: Intellectual Disability.- Neurodevelopmental Disorders: Speech and Language Disorders.- Neurodevelopmental Disorders: Autism Spectrum Disorder.- Neurodevelopmental Disorders: Attention-Deficit/ Hyperactivity Disorder.- Neurodevelopmental Disorders: Learning Disorders.- Neurodevelopmental Disorders: Stereotypical Movement Disorders and Tic Disorders.- Schizophrenia and Other Primary Psychotic Disorders.- Depressive Disorders.- Bipolar Disorders.- Premenstrual Dysphoric Disorder and Peripartum Depression.- Childhood Mood Disorders: Depressive Disorders, Bipolar Disorders, and Disruptive Mood Dysregulation Disorder.- Anxiety and Fear-Related Disorders: Generalized Anxiety Disorder.- Anxiety and Fear-Related Disorders: Social Anxiety and Specific Phobia.- Anxiety and Fear-Related Disorders: Panic Disorder and Agoraphobia.- Anxiety Anxiety Disorder in Youth: Separation Anxiety, Social Anxiety, and Generalized Anxiety Disorders.- Obsessive-Compulsive and Related Disorders.- Obsessive-Compulsive Disorder Related Disorders: Hypochondriasis, Hoarding Disorder, Olfactory Reference Disorder, Body Dysmorphic Disorder, Trichotillomania, Excoriation Disorder.- Disorders Specifically Associated with Stress: PTSD, Complex PTSD, Acute Stress Reaction, Adjustment Disorder.- Disorders Specifically Associated with Stress: Reactive attachment disorders and disinhibited social engagement disorder.- Dissociative Disorders.- Feeding and Eating Disorders.- Childhood Elimination Disorders.- Disorders of Bodily Distress and Bodily Experience.- Sleep and Sleep–Wake Disorders.- Sexual Dysfunctions.- Gender Incongruence.- Disorders Due to Substance Use: General Approaches.- Disorders Due to Substance Use: Alcohol Abuse and Addiction.- Disorders Due to Substance Use: Caffeine.- Disorders Due to Substance Use: Cannabis.- Disorders Due to Substance Use: Phencyclidine.- Disorders Due to Substance Use: Hallucinogens and MDMA-related Substances.- Disorders Due to Substance Use: Inhalants.- Disorders Due to Substance Use: Opioids and Opioid Addiction.- Disorders Due to Substance Use: Sedatives, Hypnotics, and Anxiolytics.- Disorders Due to Substance Use: Stimulants.- Disorders Due to Substance Use: Nicotine (including tobacco and vaping).- Gambling Disorder.- Internet Gaming Disorder.- Disruptive, Impulse-Control, and Conduct Disorders: Intermittent Explosive Disorder, Kleptomania, and Pyromania.- Disruptive Impulse Control and Behavior Disorders: Oppositional Defiant Disorder and Conduct Disorder.- Somatic Symptom and Related Disorders: Factitious Disorders.- Neurocognitive Disorders.- Personality Disorders.- Paraphilic Disorders.- Relational Problems.- Culture and Psychopathology.- Systems of Care.- Prevention in Psychiatry.- Mental Health Care Models in Low-and Middle-Income Countries.- The Recovery Model and Other Rehabilitative Approaches.- Psychosocial Interventions to Support Community Living: Rehabilitation, Recovery, and Rights.- Early Intervention Across Mental Health Services.- Addressing the Social Determinants of Mental Health to Achieve Equitable Clinical Care, Research, Education, and Public Policy.- Supportive Psychotherapy.- Individual Psychodynamic Psychotherapy.- Brief Psychotherapies.- Cognitive and Behavioral Therapies.- Dialectical Behavioral Therapy.- Mindfulness-Based Cognitive Therapy.- Interpersonal Psychotherapy.- Motivational Interviewing.- Hypnosis.- Group Psychotherapy.- Family and Couple Therapy.- Mindfulness-Based Interventions for Psychiatry.- Combined Psychotherapy and Somatic Treatments.- General Principles of Pharmacologic Therapy.- Neuroscience-Based Nomenclature (NbN): New Pharmacological Driven Classification of Psychotropics.- Pharmacogenomics and Precision Psychiatry.- Cultural and Ethnic Perspectives in Psychopharmacology.- Adherence to Medication in Psychiatric Disorders.- Medications for Depression: Monoamine Enhancers and Esketamine (Antidepressants).- Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics).- Medications for Bipolar Disorder.- Medications for Anxiety Disorders.- Pharmacologic Treatment of Insomnia.- Therapeutic Use of Dopamine Enhancers (Stimulants).- Cognitive Enhancers and Treatments for Alzheimer’s Disease.- Pharmacological Treatment of Substance Use Disorders.- Medical Use of Cannabinoids and Psychedelic Compounds.- Treatments for Medication-Induced Movement Disorders.- Pharmacologic Management of Reproductive Psychopathology.- Somatic Treatments and Neuromodulation in Psychiatry.- Integrative and Complementary Medicine in Psychiatry.- Placebo and Nocebo Effects: Biological and Cultural Aspects.- Integrated and CollaborativeModels of Care.- Pediatric Consultation and Liaison Psychiatry.- Psychiatric Conditions During Peripartum and Perimenopause.- Consultation-Liaison Psychiatry and Psychological Factors Affecting Other Medical Conditions.- Collaborative Care and Geriatric Psychiatry.- Determination of Decisional Capacity.- Palliative Care and Pain Management.- Death and Bereavement.- LGBTQ Individuals.- Forensic Psychiatry.- Psychiatry in Prisons and Corrections.- Intimate Partner and Sexual Violence.- Managing Psychological Consequences in Disaster Populations.- Migration Mental Health: Immigrants, Refugees, and Displaced Persons.- Victims of Torture.- Managing Workplace Mental Health: Multiple Approaches at Patient, Provider, and Systems Levels.- Modern Psychiatric Emergency Care.- Assessment and Management of Suicidal Risk.- Assessment and Management of Violent Behavior.- Assessment and Management of Agitation.- Restraint and Seclusion.- Telepsychiatry.- Integrated Digital Platforms for Clinical Care.-
Allan Tasman, M.D. is Emeritus Professor and Chair of the Department of Psychiatry and Emeritus Schwab Endowed Chair in Social and Community Psychiatry at the University of Louisville. He completed residency at the University of Cincinnati and psychoanalytic training at the Western New England Institute for Psychoanalysis. He became known nationally and internationally while a faculty member at the University of Connecticut (1976–1991) for his expertise in teaching, mentorship, and educational program development. Through his subsequent national and international work, he has been involved in a broad range of educational, clinical, strategic planning, and mental health policy issues, particularly addressing disparities in health and mental health.
His commitment to serving the disadvantaged started in medical school where he founded and was CEO of the Lexington Free Clinic. While psychiatry chair in Louisville, to address health and mental health disparities in the low-income Medicaid population, he conceptualized and spearheaded implementation of Passport Health Plan in the early 1990s. This innovative non-profit managed care organization, which prioritized the quality of health outcomes and attention to health inequities, was consistently ranked nationally in the highest levels. Passport became the second largest Medicaid system in Kentucky, with a two billion dollar annual budget. He later was a 2018–2023 appointee to the National Advisory Council of the US Substance Abuse and Mental Health Services Administration (SAMHSA).
His funded research over four decades has focused on the neurophysiology of cognitive processes. His laboratory at the University of Connecticut was one of the first to describe functional neural abnormalities in offspring of alcohol addict fathers. More recent research in Louisville focused on investigation of innovative neuromodulation treatments for autism and substance abuse. He has authored or edited 38 books, over 260 peer reviewed articles, chapters, and abstracts, nearly 80 editorials in psychiatric publications, and over 400 national and international presentations. He is founding Editor in Chief of all editions of this textbook, now named Tasman’s Psychiatry, with earlier editions called “the best current textbook of psychiatry” by the New England Journal of Medicine and the “gold standard” by the American Journal of Psychiatry. He also was Editor in Chief from 2014 to 2019 of Psychiatric Times, the psychiatric publication most widely read by psychiatrists in the United States.
He was president of the American Association of Directors of Psychiatric Residency Training, the Association for Academic Psychiatry, and two terms for the American Association of Chairs of Departments of Psychiatry. As American Psychiatric Association (APA) president elect and president, he conceptualized and established the American Psychiatric Institute for Research and Education, implemented the initial planning process for DSM 5, and initiated and oversaw a complete corporate reorganization. In 1991, he founded and was Deputy Editor of the American Psychiatric Press Journal of Psychotherapy Practice and Research.
In 2005, he was elected to a 6-year term as Secretary for Education of the World Psychiatric Association, where he produced WPA global guidelines for medical student and resident psychiatric education, with special attention to programs in resource poor countries. As President of the Pacific Rim College of Psychiatrists (2006–2008), he conceptualized and established the journal Asia Pacific Psychiatry (Editor in Chief 2014–2023), which is now also the official journal of the Asian Federation of Psychiatric Associations. It is the first transnational English language psychiatric journal focused on the entire Pacific Rim region. He currently serves as Treasurer and Vice President for North America and the Caribbean of the World Federation for Mental Health, collaborating with the WHO and UN.
He has received multiple national and international awards for leadership, educational excellence, and distinguished professional service, including an APA special presidential commendation for career leadership and service. He received distinguished alumnus awards from the University of Kentucky Medical School and Franklin and Marshall College. He is a Fellow of the Royal College of Psychiatrists of the United Kingdom and a number of other organizations including Distinguished Life Fellow of the APA, and an Honorary&nbs
Il sito utilizza cookie ed altri strumenti di tracciamento che raccolgono informazioni dal dispositivo dell’utente. Oltre ai cookie tecnici ed analitici aggregati, strettamente necessari per il funzionamento di questo sito web, previo consenso dell’utente possono essere installati cookie di profilazione e marketing e cookie dei social media. Cliccando su “Accetto tutti i cookie” saranno attivate tutte le categorie di cookie. Per accettare solo deterninate categorie di cookie, cliccare invece su “Impostazioni cookie”. Chiudendo il banner o continuando a navigare saranno installati solo cookie tecnici. Per maggiori dettagli, consultare la Cookie Policy.